Fredrik Kahn
21 – 30 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?
- Contribution to journal › Article
-
Mark
Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months
- Contribution to journal › Article
- 2022
-
Mark
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
(2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18).
- Contribution to journal › Article
-
Mark
One Scoring System Does Not Fit All Healthcare Settings
(2022) In Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(1). p.166-167
- Contribution to journal › Letter
-
Mark
Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes
- Contribution to journal › Article
-
Mark
Treatment outcome with pencillin G or cloxacillin in penicillin susceptible Staphylococcus aureus bactearemi
- Contribution to journal › Article
-
Mark
The Dynamics of Circulating Heparin-Binding Protein : Implications for Its Use as a Biomarker
- Contribution to journal › Article
-
Mark
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
- Contribution to journal › Article
-
Mark
Blood culture time to positivity in non-β-hemolytic streptococcal bacteremia as a predictor of infective endocarditis-a retrospective cohort study
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
- Contribution to journal › Article
